Noblitt & Rueland is a provider of FDA and international regulatory compliance consulting, auditing, and training services for medical device and related pharmaceutical companies. Its website highlights more than 25 years of hands-on medical device experience, serving clients from startups to Fortune 500 companies. The firm primarily helps customers address regulatory and quality system requirements such as FDA, ISO, CE Mark, MDSAP, and IEC 60601. Strictly speaking, it is not a typical SaaS or enterprise software product, but a professional consulting and training organization.
Its service portfolio is fairly comprehensive. It includes submission preparation for 510(k), IDE, PMA, CE Mark technical documentation, and related filings; quality system implementation, audits, and gap assessments for FDA QSR/GMP, ISO 13485/9001, and MDSAP; supplier audits, internal audits, and Mock FDA Inspection. On the technical compliance side, it covers design controls, ISO 14971 risk management, IEC 60601 electrical safety/EMC, software quality assurance, software V&V, IEC 62304, and 21 CFR Part 11 electronic records. Training can be delivered on-site or virtually, and can be customized for a company, department, or project team.
The website does not provide packages, subscription pricing, or standardized service bundles. It only states that estimates or proposals can be obtained via a consultation form, phone, or email. Before purchasing, buyers therefore need to clarify the project scope, consultant involvement, deliverables, timeline, and cost. In terms of delivery, consulting can be conducted remotely or on-site, while training supports both on-site and virtual formats.
Its strengths are its deep vertical expertise and coverage across multiple areas, including RA/QA, R&D, software, electrical safety, and regulatory submissions. It also uses a team-based approach to matching consulting resources, and the website notes that mock inspections can be conducted by former FDA investigators. The main drawback is the lack of key SaaS capabilities: there is no mention of a cloud platform, permission management, third-party integrations, APIs, data security certifications, online workflows, or automated document management. Pricing is also not transparent.
It is suitable for medical device companies preparing to enter the U.S., EU, or broader international markets, especially teams that need support with 510(k), CE Mark, ISO 13485, MDSAP, IEC 60601, or software V&V. For Chinese customers, the website does not state whether Chinese-language service, cross-border payment methods, or China network accessibility are supported, so china_access can only be considered unknown. If a company needs localized registration pathways, Chinese-language communication, or domestic payment options, it may consider China-based medical device regulatory consulting firms, combined with eQMS, document management, and training management systems as an alternative solution.
β This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on fdaconsultant.com official site.
fdaconsultant.com is an United States SaaS Tools provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach fdaconsultant.com directly.